CD8A and neoplasm: Overall, during localized intratumoral combination with tumor-targeting T cells, Delta-24-RGDOX downregulates the expression of immune checkpoint proteins on endogenous TAA-specific CTLs in both tumors, although their expression is upregulated on CD8+ leukocytes.